SCHEMBL31368433

SCHEMBL31368433

O=C1COC2(CC2)CN1c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.46
OPRM1 P35372 3/20 0.46
CRBN Q96SW2 1/20 0.46
GRM5 P41594 3/20 0.43
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
HIF1A Q16665 1/20 0.40
NPY5R Q15761 4/20 0.40
PDCD1 Q15116 2/20 0.39
CD274 Q9NZQ7 2/20 0.39
CYP1A2 P05177 1/20 0.39
KCNH2 Q12809 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736593 0.91 ALDH1A1 (0.50) SIGMAR1OPRM1CRBNGRM5ALDH1A1
SCHEMBL737660 0.74 HRH3 (0.49) SIGMAR1OPRM1ALDH1A1KCNH2
SCHEMBL13079376 0.72 GRM5 (0.62) CRBNGRM5NPY5RCYP1A2KCNH2
SCHEMBL736355 0.71 OPRM1 (0.38) SIGMAR1OPRM1GRM5ALDH1A1HPGD
SCHEMBL6405329 0.71 CRBN (0.49) CRBNALDH1A1HPGDHSD17B10PDCD1
SCHEMBL738190 0.70 NPY5R (0.52) GRM5ALDH1A1HPGDHSD17B10USP2
SCHEMBL28480423 0.70 CYP1A2 (0.51) CRBNALDH1A1HPGDHSD17B10USP2
SCHEMBL14094863 0.70 GRM5 (0.50) SIGMAR1OPRM1GRM5NPY5RCYP1A2
SCHEMBL3741402 0.70 GRM5 (0.50) SIGMAR1OPRM1GRM5NPY5RCYP1A2
SCHEMBL3740531 0.70 GRM5 (0.50) SIGMAR1OPRM1GRM5NPY5RCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739685-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP claimed
WO-2025008061-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 WO claimed